 |
Code of Federal Regulations (Last Updated: November 8, 2024) |
 |
Title 40 - Protection of Environment |
|
Chapter I - Environmental Protection Agency |
|
SubChapter D - Water Programs |
|
Part 141 - National Primary Drinking Water Regulations |
|
Subpart E - Special Regulations, Including Monitoring Regulations and Prohibition on Lead Use |
§ 141.40 - Monitoring requirements for unregulated contaminants.
-
§ 141.40 Monitoring requirements for unregulated contaminants.
(a) General applicability. This section specifies the monitoring and quality control requirements that must be followed if you own or operate a public water system (PWS) that is subject to the Unregulated Contaminant Monitoring Regulation (UCMR), as specified in paragraphs (a)(1) and (2) of this section. In addition, this section specifies the UCMR requirements for State and Tribal participation. For the purposes of this section, PWS “population served,” “State,” ” PWS Official,” “PWS Technical Contact,” and “finished water” apply as defined in § 141.35(a). The determination of whether a PWS is required to monitor under this rule is based on the type of system (e.g., community water system, non-transient non-community water system, etc.), and its retail population, as indicated by SDWIS/Fed on December 31, 2015February 1, 2021 or subsequent corrections from the State.
(1) Applicability to transient non-community systems. If you own or operate a transient non-community water system, you are not subject to monitoring requirements in this section.
(2) Applicability to community water systems and non-transient non-community water systems -
(i) Large systems. If you own or operate a retail PWS (other than a transient non-community system) that serves more than 10,000 people, you must monitor according to the specifications in this paragraph (a)(2)(i). If you believe that your applicability status is different than EPA has specified in the notification letter that you received, or if you are subject to UCMR requirements and you have not been notified by either EPA or your State, you must report to EPA, as specified in § 141.35(b)(2) or (c)(4).
(A) Assessment monitoring. You must monitor for the contaminants on List 1, per Table 1, UCMR Contaminant List, in paragraph (a)(3) of this section. If you serve a retail population of more than 10,000 people, you are required to perform this monitoring regardless of whether you have been notified by the State or EPA.
(B) Screening Survey. You must monitor for the unregulated contaminants on List 2 (Screening Survey) of Table 1, as specified in paragraph (a)(3) of this section, if your system serves 10,001 to 100,000 people and you are notified by EPA or your State that you are part of the State Monitoring Plan for Screening Survey testing. If your system serves more than 100,000 people, you are required to conduct this Screening Survey testing regardless of whether you have been notified by the State or EPA.
(C) Pre-Screen Testing. You must monitor for the unregulated contaminants on List 3 of Table 1, in paragraph (a)(3) of this section, if notified by your State or EPA that you are part of the Pre-Screen Testing.
(ii) Small systems. Small PWSs, as defined in this paragraph, will not be selected to monitor for any more than one of the three monitoring lists provided in Table 1, UCMR Contaminant List, in paragraph (a)(3) of this section. EPA will provide sample containers, provide pre-paid air bills for shipping the sampling materials, conduct the laboratory analysis, and report and review monitoring results for all small systems selected to conduct monitoring under paragraphs (a)(2)(ii)(A) through (C) of this section. If you own or operate a PWS (other than a transient non-community water system) that serves a retail population of 10,000 or fewer people and you are notified of monitoring requirements by the State or EPA, you must monitor as follows:
(A) Assessment monitoringMonitoring. You must monitor for the contaminants on List 1 per Table table 1 , in to paragraph (a)(3) of this section, if you are notified by your State or EPA that you are part of the State Monitoring Plan for Assessment Monitoring.
(B) Screening Survey. You must monitor for the unregulated contaminants on List 2 of Table 1, in paragraph (a)(3) of this section, if notified by your State or EPA that you are part of the State Monitoring Plan for the Screening Survey.
(C) Pre-screen testing. You must monitor for the contaminants on List 3 of Table 1, in paragraph (a)(3) of this section if you are notified by your State or EPA that you are part of the State Monitoring Plan for Pre-Screen Testing.
(3) Analytes to be monitored. Lists 1, 2, and 3 contaminants are provided in the following tabletable 1 to paragraph (a)(3):
Table 1 to Paragraph (a)(3) - UCMR Contaminant List
1 - Contaminant 2 - CAS Registry No. CASRN 3 - Analytical
methodsa4 - Minimum
reporting levelb5 - Sampling
locationc6 - Period during
which monitoring sample
collection
to be completedList 1: Assessment Monitoring Cyanotoxin Chemical Contaminants “total microcystin” N/A EPA 546 0.3Per- and Polyfluoroalkyl Substances (PFAS) 11-chloroeicosafluoro-3-oxaundecane-1-sulfonic acid (11Cl-PF3OUdS) 763051-92-9 EPA 533 0.005 µg/L EPTDS 31/1/20182023-1112/30/2020. anatoxin-a 64285-06-9 EPA 545 0.03 31/2025 1H, 1H, 2H, 2H-perfluorodecane sulfonic acid (8:2 FTS) 39108-34-4 EPA 533 0.005 µg/L EPTDS 31/1/20182023-1112/30/2020. cylindrospermopsin 143545-90-8 EPA 545 0.09 31/2025 1H, 1H, 2H, 2H-perfluorohexane sulfonic acid (4:2 FTS) 757124-72-4 EPA 533 0.003 µg/L EPTDS 31/1/20182023-1112/30/2020. microcystin-LA 96180-79-9 EPA 544 0.008 31/2025 1H, 1H, 2H, 2H-perfluorooctane sulfonic acid (6:2 FTS) 27619-97-2 EPA 533 0.005 µg/L EPTDS 31/1/20182023-1112/30/2020. microcystin-LF 154037-70-4 EPA 544 0.006 31/2025 4,8-dioxa-3H-perfluorononanoic acid (ADONA) 919005-14-4 EPA 533 0.003 µg/L EPTDS 31/1/20182023-1112/30/2020. microcystin-LR 101043-37-2 EPA 544 0.02 31/2025 9-chlorohexadecafluoro-3-oxanone-1-sulfonic acid (9Cl-PF3ONS) 756426-58-1 EPA 533 0.002 µg/L EPTDS 31/1/20182023-1112/30/2020. microcystin-LY 123304-10-9 EPA 544 0.009 31/2025 hexafluoropropylene oxide dimer acid (HFPO-DA) (GenX) 13252-13-6 EPA 533 0.005 µg/L EPTDS 31/1/20182023-1112/30/2020. microcystin-RR 111755-37-4 EPA 544 0.006 31/2025 nonafluoro-3,6-dioxaheptanoic acid (NFDHA) 151772-58-6 EPA 533 0.02 µg/L EPTDS 31/1/20182023-1112/30/2020. microcystin-YR 101064-48-6 EPA 544 0.02 31/2025 perfluoro (2-ethoxyethane) sulfonic acid (PFEESA) 113507-82-7 EPA 533 0.003 µg/L EPTDS 31/1/20182023-1112/30/2020. nodularin 118399-22-7 EPA 544 0.005 31/2025 perfluoro-3-methoxypropanoic acid (PFMPA) 377-73-1 EPA 533 0.004 µg/L EPTDS 31/1/20182023-1112/30/2020. List 1: Assessment Monitoring Additional Chemical Contaminants Metals germanium 7440-56-4 EPA 200.8, ASTM D5673-10, SM 3125 0.3 31/2025 perfluoro-4-methoxybutanoic acid (PFMBA) 863090-89-5 EPA 533 0.003 µg/L EPTDS 1/1/20182023-12/31/2020. manganese 7439-962025 perfluorobutanesulfonic acid (PFBS) 375-73-5 EPA 200.8, ASTM D5673-10, SM 3125533 0.4 003 µg/L EPTDS 1/1/20182023-12/31/2020. Pesticides and a Pesticide Manufacturing Byproduct alpha-hexachlorocyclohexane 319-84-6 EPA 525.3 0.01 2025 perfluorobutanoic acid (PFBA) 375-22-4 EPA 533 0.005 µg/L EPTDS 1/1/20182023-12/31/2020. chlorpyrifos 2921-882025 perfluorodecanoic acid (PFDA) 335-76-2 EPA 525.3533 0.03 003 µg/L EPTDS 1/1/20182023-12/31/2020. dimethipin 55290-64-7 EPA 525.3 0.2 2025 perfluorododecanoic acid (PFDoA) 307-55-1 EPA 533 0.003 µg/L EPTDS 1/1/20182023-12/31/2020. ethoprop 13194-48-4 EPA 525.3 0.03 2025 perfluoroheptanesulfonic acid (PFHpS) 375-92-8 EPA 533 0.003 µg/L EPTDS 1/1/20182023-12/31/2020. oxyfluorfen 42874-03-3 EPA 525.3 0.05 2025 perfluoroheptanoic acid (PFHpA) 375-85-9 EPA 533 0.003 µg/L EPTDS 1/1/20182023-12/31/2020. profenofos 41198-08-7 EPA 525.3 0.3 2025 perfluorohexanesulfonic acid (PFHxS) 355-46-4 EPA 533 0.003 µg/L EPTDS 1/1/20182023-12/31/2020. tebuconazole 107534-96-3 EPA 525.3 0.2 2025 perfluorohexanoic acid (PFHxA) 307-24-4 EPA 533 0.003 µg/L EPTDS 1/1/20182023-12/31/2020. total permethrin (cis- & trans-) 52645-532025 perfluorononanoic acid (PFNA) 375-95-1 EPA 525.3533 0.04 004 µg/L EPTDS 1/1/20182023-12/31/2020. tribufos 78-48-8 EPA 525.3 0.07 2025 perfluorooctanesulfonic acid (PFOS) 1763-23-1 EPA 533 0.004 µg/L EPTDS 1/1/20182023-12/31/2020. Brominated Haloacetic Acid (HAA) Groups d e HAA5 N/A EPA 552.3 or EPA 557 N/A D/DBPR HAA location 2025 perfluorooctanoic acid (PFOA) 335-67-1 EPA 533 0.004 µg/L EPTDS 1/1/20182023-12/31/2020. HAA6Br N/A EPA 552.3 or EPA 557 N/A D/DBPR HAA location 2025 perfluoropentanesulfonic acid (PFPeS) 2706-91-4 EPA 533 0.004 µg/L EPTDS 1/1/20182023-12/31/2020. HAA9 N/A EPA 552.3 or EPA 557 N/A D/DBPR HAA location 2025 perfluoropentanoic acid (PFPeA) 2706-90-3 EPA 533 0.003 µg/L EPTDS 1/1/20182023-12/31/2020. Alcohols 1-butanol 71-36-3 EPA 541 2.0 2025 perfluoroundecanoic acid (PFUnA) 2058-94-8 EPA 533 0.002 µg/L EPTDS 1/1/20182023-12/31/2020. 2-methoxyethanol 109-86-4 EPA 541 0.4 2025 n-ethyl perfluorooctanesulfonamidoacetic acid (NEtFOSAA) 2991-50-6 EPA 537.1 0.005 µg/L EPTDS 1/1/20182023-12/31/2020. 2-propen-1-ol 107-18-6 EPA 541 0.5 2025 n-methyl perfluorooctanesulfonamidoacetic acid (NMeFOSAA) 2355-31-9 EPA 537.1 0.006 µg/L EPTDS 1/1/20182023-12/31/2020. Other Semivolatile Chemicals butylated hydroxanisole 25013-16-5 EPA 530 0.03 2025 perfluorotetradecanoic acid (PFTA) 376-06-7 EPA 537.1 0.008 µg/L EPTDS 1/1/20182023-12/31/2020. o-toluidine 95-53-4 EPA 530 2025 perfluorotridecanoic acid (PFTrDA) 72629-94-8 EPA 537.1 0.007 µg/L EPTDS 1/1/20182023-12/31/2020. quinoline 91-22-5 EPA 530 0.02 2025 Metal/Pharmaceutical Lithium 7439-93-2 EPA 200.7, SM 3120 B, ASTM D1976-20 9 µg/L EPTDS 1/1/20182023-12/31/2020. 2025 List 2: Screening Survey Reserved Reserved Reserved Reserved Reserved Reserved . List 3: Pre-Screen Testing Reserved Reserved Reserved Reserved Reserved Reserved . D/DBPR) sampling locations (40 CFR 141.622). d UCMR(
HAA monitoring applies only to those PWSs that are subject to D/DBPR HAA5 monitoring requirements. e PWSs that purchase 100 percent of their water (“consecutive systems”4
are not required to collect UCMR 4 source water samples for TOC or bromide analyses.)
for TOC and bromide must otherwise occur at source water influent locations representing untreated water entering the water treatment plant (i.e., a location prior to any treatment). SW and GWUDI systems subject to the D/DBPR TOC monitoring must use their D/DBPR TOC source water sampling site(s) from 40 CFR 141.132 for UCMR 4 TOC and bromide samples. SW and GWUDI systems that are not subject to D/DBPR TOC monitoring will use their Long Term 2 Enhance Surface Water Treatment Rule (LT2) source water sampling site(s) (40 CFR 141.703) for UCMR 4 TOC and bromide samples. Ground water systems that are subject to the D/DBPRs, and therefore subject to UCMR 4 HAA monitoring, will take TOC and bromide samples at their influents entering their treatment train. TOC and bromide must be collected at the same time as HAA samples. These indicator samples must be collected at a single source water influent using methods already approved for compliance monitoring. TOC methods include: SM 5310 B, SM 5310 C, SM 5310 D (21st edition), or SM 5310 B-00, SM 5310 C-00, SM 5310 D-00 (SM Online), EPA Method 415.3 (Rev. 1.1 or 1.2). Bromide methods include: EPA Methods 300.0 (Rev. 2.1), 300.1 (Rev. 1.0), 317.0 (Rev. 2.0), 326.0 (Rev. 1.0) or ASTM D 6581-12. The MRLs for the individual HAAs are discussed in paragraph (a)(5)(v) of this section.Sampling
(4) Sampling requirements -
(i) Large systems. If you serve more than 10,000 people and meet the UCMR applicability criteria specified in paragraph (a)(2)(i) of this section, you must comply with the requirements specified in paragraphs (a)(4)(i)(A) through (I) of this section. Your samples must be collected according to the schedule that you are assigned by EPA or your State, or the schedule that you revised using EPA's electronic data reporting system on or before December 31, 20172022. Your schedule must follow both the timing and frequency of monitoring specified in Tables 1 and 2 of this section.
(A) Monitoring Sample collection period. You must collect the samples in one continuous 12-month period for List 1 Assessment Monitoring, and, if applicable, for List 2 Screening Survey, or List 3 Pre-Screen Testing, during the time frame timeframe indicated in column 6 of Table table 1 , in to paragraph (a)(3) of this section. EPA or your State will specify the month(s) and year(s) in which your monitoring must occur. As specified in § 40 CFR 141.35(c)(5), you must contact EPA if you believe you cannot conduct monitoring collect samples according to your schedule.
(B) Frequency. You must collect the samples within the timeframe and according to the frequency specified by contaminant type and water source type for each sampling location, as specified in Table table 2 , in to this paragraph (a)(4)(i)(B). For the second or subsequent round of sampling, if a sample location is non-operational for more than one month before and one month after the scheduled sampling month (i.e., it is not possible for you to sample within the window specified in Table table 2, in this paragraph), you must notify EPA as specified in § 40 CFR 141.35(c)(5) to reschedule your sampling.
Table 2 to Paragraph (a)(4)(i)(B) - Monitoring Frequency by Contaminant and Water Source Types
Contaminant type Water source type Timeframe Frequency1 List 1 Cyanotoxins Chemicals Surface water or Ground water under the direct influence of surface water (GWUDI) March-November You must monitor twice a month for four consecutive months (total of eight sampling events). Sample events must occur two weeks apart. List 1 Contaminants - Additional Chemicals Surface water, Mixed, or GWUDI 12 months You must monitor for four consecutive quarters. Sample events must occur three months apart. (Example: If first monitoring is in January, the second monitoring must occur any time in April, the third any time in July, and the fourth any time in October). Ground water 12 months You must monitor twice in a consecutive 12-month period. Sample events must occur 5-7 months apart. (Example: If the first monitoring event is in April, the second monitoring event must occur any time in September, October, or November.) . (C) Location. You must collect samples for each List 1 Assessment Monitoring contaminant, and, if applicable, for each List 2 Screening Survey, or List 3 Pre-Screen Testing contaminant, as specified in Table table 1 , in to paragraph (a)(3) of this section. Samples must be collected at each sample point that is specified in column 5 and footnote c of Table table 1 , in to paragraph (a)(3) of this section. PWSs conducting List 1 monitoring for the brominated HAA groups must collect TOC and bromide samples as specified in footnote d of Table 1, in paragraph (a)(3) of this section. If you are a GW system with multiple EPTDSs, and you request and receive approval from EPA or the State for sampling at representative EPTDS(s), as specified in § 40 CFR 141.35(c)(3), you must collect your samples from the approved representative sampling location(s).
(D) Sampling instructions. For each List 1 Assessment Monitoring contaminant, and, if applicable, for each List 2 Screening Survey, or List 3 Pre-Screen Testing contaminant, you must follow the sampling procedure for the method specified in column 3 of Table 1, in paragraph (a)(3) of this section. In addition, you must not composite (that is, combine, mix, or blend) the samples; you must collect and preserve each sample separately.
(E) Sample collection and shipping time. If you must ship the samples for analysis, you must collect the samples early enough in the day to allow adequate time to send the samples for overnight delivery to the laboratory. You should not collect samples on Friday, Saturday, or Sunday because sampling on these days may not allow samples to be shipped and received at the laboratory at the required temperature, unless you have made special arrangements with your laboratory to receive the samples.
(F) Analytical methods. For each contaminant, you must use the respective analytical methods for List 1, and, if applicable, for List 2, or List 3 that are specified in column 3 of Table 1, in paragraph (a)(3) of this section; report values at or above the minimum reporting levels for List 1, and, if applicable, for List 2 Screening Survey, or List 3 Pre-Screen Testing, that are specified in column 4 of Table 1, in paragraph (a)(3) of this section; and conduct the quality control procedures specified in paragraph (a)(5) of this section.
(G) Laboratory errors or sampling deviations. If the laboratory data do not meet the required QC criteria, as specified in paragraph (a)(5) of this section, or you do not follow the required sampling procedures, as specified in paragraphs (a)(4) of this section, you must resample within 30 days of being informed or becoming aware of these facts. This resampling is not for the purpose of confirming previous results, but to correct the sampling or laboratory error. All systems must report the results obtained from the first sampling for each sampling period, except for cases of sampling or laboratory errors. For the purposes of this rule, no samples are to be recollected for the purposes of confirming the results observed in a previous sampling.
(H) Analysis. For the List 1 contaminants, and, if applicable, List 2 Screening Survey, or List 3 Pre-Screen Testing contaminants, identified in Table 1, paragraph (a)(3) of this section, you must arrange for testing by a laboratory that has been approved by EPA according to requirements in paragraph (a)(5)(ii) of this section.
(I) Review and reporting of results. After you have received the laboratory results, you must review, approve, and submit the system information, and sample collection data and test results. You must report the results as provided in § 141.35(c)(6).
(ii) Small systems. If you serve a population of 10,000 or fewer people and are notified that you are part of the State Monitoring Plan for Assessment Monitoring, Screening Survey or Pre-Screen monitoring, you must comply with the requirements specified in paragraphs (a)(4)(ii)(A) through (H) of this section. If EPA or the State informs you that they will be collecting your UCMR samples, you must assist them in identifying the appropriate sampling locations and in collecting the samples.
(A) Monitoring period Sample collection and frequency. You must collect samples at the times specified for you by the State or EPA. Your schedule must follow both the timing of monitoring specified in Table 1table 1 to paragraph (a)(3) of this section, List 1, and, if applicable, List 2, or List 3, and the frequency of monitoring in Table 2 table 2 to paragraph (a)(4)(i)(B) of this section.
(B) Location. You must collect samples at the locations specified for you by the State or EPA.
(C) Sample kits. You must store and maintain the sample collection kits sent to you by the UCMR Sampling Coordinator in accordance with the kit's instructions. The sample kit will include all necessary containers, packing materials and cold packs, instructions for collecting the sample and sample treatment (such as dechlorination or preservation), report forms for each sample, contact name and telephone number for the laboratory, and a prepaid return shipping docket and return address label. If any of the materials listed in the kit's instructions are not included in the kit or arrive damaged, you must notify the UCMR Sampling Coordinator who sent you the sample collection kits.
(D) Sampling instructions. You must comply with the instructions sent to you by the State or EPA concerning the use of containers, collection (how to fill the sample bottle), dechlorination and/or preservation, and sealing and preparation of sample and shipping containers for shipment. You must not composite (that is, combine, mix, or blend) the samples. You also must collect, preserve, and test each sample separately. You must also comply with the instructions sent to you by the UCMR Sampling Coordinator concerning the handling of sample containers for specific contaminants.
(E) Sampling deviations. If you do not collect a sample according to the instructions provided to you for a listed contaminant, you must report the deviation within 7 days of the scheduled monitoring on the sample reporting form, as specified in § 141.35(d)(2). You must resample following instructions that you will be sent from the UCMR Sampling Coordinator or State. A copy of the form must be sent to the laboratory with the recollected samples, and to the UCMR Sampling Coordinator.
(F) [Reserved]
(G) Sampling forms. You must completely fill out each of the sampling forms and bottles sent to you by the UCMR Sampling Coordinator, including data elements listed in § 141.35(e) for each sample, as specified in § 141.35(d)(2). You must sign and date the sampling forms.
(H) Sample collection and shipping. You must collect the samples early enough in the day to allow adequate time to send the samples for overnight delivery to the laboratory. You should not collect samples on Friday, Saturday, or Sunday because sampling on these days may not allow samples to be shipped and received at the laboratory at the required temperature unless you have made special arrangements with EPA for the laboratory to receive the samples. Once you have collected the samples and completely filled in the sampling forms, you must send the samples and the sampling forms to the laboratory designated on the air bill.
iii) Phased sample analysis for microcystins. You must collect the three required samples (one each for EPA Methods 544, 545 and 546 (ELISA) at the EPTDS) for each sampling event, but not all samples may need to be analyzed. If the Method 546 ELISA result is less than 0.3 µg/L, report that result and do not analyze the EPA Method 544 sample for that sample event. If the Method 546 ELISA result is greater than or equal to 0.3 µg/L, report the value and analyze the other microcystin sample using EPA Method 544. You must analyze the EPA Method 545 sample for each sample event for Cylindrospermopsin and anatoxin-a only.(
(5) Quality control requirements. If your system serves more than 10,000 people, you must ensure that the quality control requirements listed below are met during your sampling procedures and by the laboratory conducting your analyses. You must also ensure that all method quality control procedures and all UCMR quality control procedures are followed.
(i) Sample collection/preservation. You must follow the sample collection and preservation requirements for the specified method for each of the contaminants in Table 1, in paragraph (a)(3) of this section. These requirements specify sample containers, collection, dechlorination, preservation, storage, sample holding time, and extract storage and/or holding time that you must assure that the laboratory follow.
(ii) Laboratory approval for Lists 1, List 2 and List 3. To be approved to conduct UCMR testing, the laboratory must be certified under § 141.28 for one or more compliance analyses; demonstrate for each analytical method it plans to use for UCMR testing that it can meet the Initial Demonstration of Capability (IDC) requirements detailed in the analytical methods specified in column 3 of Table 1, in paragraph (a)(3) of this section; and successfully participate in the UCMR Proficiency Testing (PT) Program administered by EPA for each analytical method it plans to use for UCMR testing. UCMR laboratory approval decisions will be granted on an individual method basis for the methods listed in column 3 of Table 1 in paragraph (a)(3) of this section for List 1, List 2, and List 3 contaminants. Laboratory approval is contingent upon the capability of the laboratory to post monitoring data to the EPA electronic data reporting system. To participate in the UCMR Laboratory Approval Program, the laboratory must register and complete and submit the necessary registration forms by February 21, 2017, and necessary application material April 19, 2017application materials by August 1, 2022. Correspondence must be addressed to: UCMR Laboratory Approval Coordinator, USEPA, Technical Support Center, 26 West Martin Luther King Drive, (MS 140), Cincinnati, OH Ohio 45268; or emailed to EPA at: UCMR_SamplingLab_Coordinator@epaApproval@epa.gov.
(iii) Minimum Reporting Level. The MRL is an estimate of defined by EPA as the quantitation limit . Assuming good instrumentation and experienced analysts, an MRL is achievable, with 95% 95 percent confidence, by 75% 75 percent of laboratories nationwide, assuming the use of good instrumentation and experienced analysts.
(A) Validation of laboratory performance. Your laboratory must be capable of quantifying each contaminant listed in Table 1, at or below the MRL specified in column 4 of Table 1, in paragraph (a)(3) of this section. You must ensure that the laboratory completes and has on file and available for your inspection, records of two distinct procedures. First, your laboratory must have conducted an IDC involving replicate analyses at or below the MRL as described in this paragraph. Second, for each day that UCMR analyses are conducted by your laboratory, a validation of its ability to quantify each contaminant, at or below the MRL specified in column 4 of Table 1, in paragraph (a)(3) of this section, following the procedure listed in paragraph (a)(5)(iii)(B) of this section, must be performed. The procedure for initial validation of laboratory performance at or below the MRL is as follows:
(1) All laboratories performing analysis under UCMR must demonstrate that they are capable of meeting data quality objectives at or below the MRL listed in Table 1, column 4, in paragraph (a)(3) of this section.
(2) The MRL, or any concentration below the MRL, at which performance is being evaluated, must be contained within the range of calibration. The calibration curve regression model and the range of calibration levels that are used in these performance validation steps must be used in all routine sample analyses used to comply with this regulation. Only straight line or quadratic regression models are allowed. The use of either weighted or unweighted models is permitted. The use of cubic regression models is not permitted.
(3) Replicate analyses of at least seven (7) fortified samples in reagent water must be performed at or below the MRL for each analyte, and must be processed through the entire method procedure (i.e., including extraction, where applicable, and with all preservatives).
(4) A prediction interval of results (PIR), which is based on the estimated arithmetic mean of analytical results and the estimated sample standard deviation of measurement results, must be determined by Equation 1:
Where:
t is the Student's t value with df degrees of freedom and confidence level (1-α),
s is the sample standard deviation of n replicate samples fortified at the MRL,
n is the number of replicates.
(5) The values needed to calculate the PIR using Equation 1 are: Number of replicates (n); Student's t value with a two-sided 99% confidence level for n number of replicates; the average (mean) of at least seven replicates; and the sample standard deviation. Factor 1 is referred to as the Half Range PIR (HRPIR).
For a certain number of replicates and for a certain confidence level in Student's t, this factor
is constant, and can be tabulated according to replicate number and confidence level for the Student's t. Table 3 in this paragraph lists the constant factor (C) for replicate sample numbers 7 through 10 with a confidence level of 99% for Student's t.
(6) The HRPIR is calculated by Equation 2:
(7) The PIR is calculated by Equation 3:
Table 3 - The Constant Factor (C) to be Multiplied by the Standard Deviation to Determine the Half Range Interval of the PIR (Student's t 99% Confidence Level) a
Replicates Degrees of freedom Constant factor (C) to be multiplied by the standard
deviation7 6 3.963 8 7 3.711 9 8 3.536 10 9 3.409 (8) The lower and upper result limits of the PIR must be converted to percent recovery of the concentration being tested. To pass criteria at a certain level, the PIR lower recovery limits cannot be lower than the lower recovery limits of the QC interval (50%), and the PIR upper recovery limits cannot be greater than the upper recovery limits of the QC interval (150%). When either of the PIR recovery limits falls outside of either bound of the QC interval of recovery (higher than 150% or less than 50%), laboratory performance is not validated at the concentration evaluated. If the PIR limits are contained within both bounds of the QC interval, laboratory performance is validated for that analyte.
(B) Quality control requirements for validation of laboratory performance at or below the MRL.
(1) You must ensure that the calibration curve regression model and that the range of calibration levels that are used in these performance validation steps are used in future routine sample analysis. Only straight line or quadratic regression models are allowed. The use of either weighted or unweighted models is permitted. The use of cubic regression models is not permitted.
(2) You must ensure, once your laboratory has performed an IDC as specified in each analytical method (demonstrating that DQOs are met at or below an MRL), that a daily performance check is performed for each analyte and method. A single laboratory blank, fortified at or below the MRL for each analyte, must be processed through the entire method procedure. The measured concentration for each analyte must be converted to a percent recovery, and if the recovery is within 50%-150% (inclusive), the daily performance of the laboratory has been validated. The results for any analyte for which 50%-150% recovery cannot be demonstrated during the daily check are not valid. Laboratories may elect to re-run the daily performance check sample if the performance for any analyte or analytes cannot be validated. If performance is validated for these analytes, the laboratory performance is considered validated. Alternatively, the laboratory may re-calibrate and repeat the performance validation process for all analytes.
((iv) Laboratory fortified sample matrix and laboratory fortified sample matrix duplicate. You must ensure that your laboratory prepares and analyzes the Laboratory Fortified Sample Matrix (LFSM) sample for accuracy and Laboratory Fortified Sample Matrix Duplicate (LFSMD) samples for precision to determine method accuracy and precision for all contaminants in Table 1, in paragraph (a)(3) of this section. LFSM/LFSMD samples must be prepared using a sample collected and analyzed in accordance with UCMR requirements and analyzed at a frequency of 5% (or 1 LFSM/LFSMD set per every 20 samples) or with each sample batch, whichever is more frequent. In addition, the LFSM/LFSMD fortification concentrations must be alternated between a low-level fortification and mid-level fortification approximately 50% of the time. (For example: A set of 40 samples will require preparation and analysis of 2 LFSM/LFSMD paired samples. The first LFSM/LFSMD paired sample set must be fortified at either the low-level or mid-level, and the second LFSM/LFSMD paired sample set must be fortified with the other standard, either the low-level or mid-level, whichever was not used for the initial LFSM/LFSMD paired sample set.) The low-level LFSM/LFSMD fortification concentration must be within ±50% of the MRL for each contaminant (e.g., for an MRL of 1 µg/L the acceptable fortification levels must be between 0.5 µg/L and 1.5 µg/L). The mid-level LFSM/LFSMD fortification concentration must be within ±20% of the mid-level calibration standard for each contaminant, and is to represent, where possible and where the laboratory has data from previously analyzed samples, an approximate average concentration observed in previous analyses of that analyte. There are no UCMR contaminant recovery acceptance criteria specified for LFSM/LFSMD analyses. All LFSM/LFSMD data are to be reported.
[Reserved]
(v) Method defined quality control. You must ensure that your laboratory analyzes Laboratory Fortified Blanks and conducts Laboratory Performance Checks, as appropriate to the method's requirements, for those methods listed in Table 1, column 3 , in table 1 to paragraph (a)(3) of this section. Each method specifies acceptance criteria for these QC checks. The following HAA results must be reported using EPA's electronic data reporting system for quality control purposes.
Table 4 - HAA QC Results
1 - Contaminant 2 - CAS Registry No. 3 - Analytical methodsa 4 - Minimum reporting levelb5 - HAA6Br Group 6 - HAA9 Group 7 - HAA5 Group Brominated Haloacetic AcidHAA) Groups(
Bromochloroacetic acid (BCAA) 5589-96-8 EPA 552.3 or EPA 557 0.3 µg/L Bromodichloroacetic acid (BDCAA) 71133-14-7 EPA 552.3 or EPA 557 0.5 µg/L Chlorodibromoacetic acid (CDBAA) 5278-95-5 EPA 552.3 or EPA 557 0.3 µg/L HAA6Br Tribromoacetic acid (TBAA) 75-96-7 EPA 552.3 or EPA 557 2.0 µg/L Monobromoacetic acid (MBAA) 79-08-3 EPA 552.3 or EPA 557 0.3 µg/L Dibromoacetic acid (DBAA) 631-64-1 EPA 552.3 or EPA 557 0.3 µg/L HAA9 Dichloroacetic acid (DCAA) 79-43-6 EPA 552.3 or EPA 557 0.2 µg/L Monochloroacetic acid (MCAA) 79-11-8 EPA 552.3 or EPA 557 2.0 µg/L HAA5 Trichloroacetic acid (TCAA) 76-03-9 EPA 552.3 or EPA 557 0.5 µg/L (vi) Reporting. You must require your laboratory to submit these data electronically to the State and EPA using EPA, on your behalf, to post and approve these data in EPA's electronic data reporting system, accessible at https://www.epa.gov/dwucmr, for your review within 120 90 days from the sample collection date. You then have 60 30 days from when the laboratory posts the and approves your data to review, approve, and submit the data to the State and EPA, via EPAthe agency's electronic data reporting system. If you do not electronically approve and submit the laboratory data to EPA within 60 30 days of the laboratory posting approved data to EPA's electronic reporting system, the data will be considered approved by you and available for State and EPA review.
(6) Violation of this rule -
(i) Monitoring violations. Any failure to monitor in accordance with § 141.40(a)(3)-(5) is a monitoring violation.
(ii) Reporting violations. Any failure to report in accordance with § 141.35 is a reporting violation.
(b) Petitions and waivers by States -
(1) Governors' petition for additional contaminants. The Safe Drinking Water Act allows Governors of seven (7) or more States to petition the EPA Administrator to add one or more contaminants to the UCMR Contaminant List in paragraph (a)(3) of this section. The petition must clearly identify the reason(s) for adding the contaminant(s) to the monitoring list, including the potential risk to public health, particularly any information that might be available regarding disproportional risks to the health and safety of children, the expected occurrence documented by any available data, any analytical methods known or proposed to be used to test for the contaminant(s), and any other information that could assist the Administrator in determining which contaminants present the greatest public health concern and should, therefore, be included on the UCMR Contaminant List in paragraph (a)(3) of this section.
(2) State-wide waivers. A State can waive monitoring requirements only with EPA approval and under very limited conditions. Conditions and procedures for obtaining a waiver are as follows:
(i) Application. A State may apply to EPA for a State-wide waiver from the unregulated contaminant monitoring requirements for PWSs serving more than 10,000 people. To apply for such a waiver, the State must submit an application to EPA that includes the following information: The list of contaminants on the UCMR Contaminant List for which a waiver is requested, along with documentation for each contaminant in the request demonstrating that the contaminants or their parent compounds do not occur naturally in the State, and certifying that during the past 15 years they have not been used, applied, stored, disposed of, released, or detected in the source waters or distribution systems in the State.
(ii) Approval. EPA will review State applications and notify the State whether it accepts or rejects the request. The State must receive written approval from EPA before issuing a State-wide waiver.
[(c) Incorporation by reference. These The standards required in this section are incorporated by reference into this section with the approval of the Director of the Federal Register under 5 U.S.C. 552(a) and 1 CFR part 51. All approved material is available for inspection either electronically at http://www.regulations.gov, in hard copy at the at U.S. Environmental Protection Agency, Water Docket, EPA/DC, and from the sources as follows. The Public Reading Room ( EPA West, Room 3334, 1301 Constitution Ave. NW., Washington, DC ) is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for this Public Reading Room is 20004, (202) 566-1744, and the telephone number for the Water Docket is (202) 566-2426. email Docket-customerservice@epa.gov, or go to https://www.epa.gov/dockets/epa-docket-center-reading-room, and is available from the sources indicated elsewhere in this paragraph. The material is also available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call (202) 741-6030 email fr.inspection@nara.gov, or go to http://www.archives.gov/federal-register/cfr/aboutibr-locations.html.
(1) U.S. Environmental Protection Agency, Water Docket, EPA /DC, EPA West, Room 3334, 1301 Constitution Ave. NW., Washington, DC 20004; telephone: (202) 566-1744.
(ix) Method 530 “Determination of Select Semivolatile Organic Chemicals(i) Method 200.8 7, “Determination of Metals and Trace Elements in Waters Water and Wastes by Inductively Coupled Plasma- Mass Atomic Emission Spectrometry,” Revision 54.4, EMMC Version, 1994. Available on the Internet at https://www.nemi.gov.
(ii) Method 300.0 “Determination of Inorganic Anions by Ion Chromatography Samples,” Revision 2.1, August 1993. Available on the Internet at https://www.nemi.gov.
(iii) Method 300.1 “Determination of Inorganic Anions in Drinking Water by Ion Chromatography,” Revision 1.0, 1997. Available on the Internet at https://www.epa.gov/dwanalyticalmethods.
(iv) Method 317.0 “Determination of Inorganic Oxyhalide Disinfection By-Products in Drinking Water Using Ion Chromatography with the Addition of a Postcolumn Reagent for Trace Bromate Analysis,” Revision 2.0, July 2001, EPA 815-B-01-001. Available on the Internet at https://www.epa.gov/dwanalyticalmethods.
(v) Method 326.0 “Determination of Inorganic Oxyhalide Disinfection By-Products in Drinking Water Using Ion Chromatography Incorporating the Addition of a Suppressor Acidified Postcolumn Reagent for Trace Bromate Analysis,” Revision 1.0, June 2002, EPA 815-R-03-007. Available on the Internet at https://www.epa.gov/dwanalyticalmethods.
(vi) Method 415.3 “Determination of Total Organic Carbon and Specific UV Absorbance at 254 nm in Source Water and Drinking Water,” Revision 1.1, February 2005, EPA/600/R-05/055. Available on the Internet at https://www.epa.gov/water-research/epa-drinking-water-research-methods.
(vii) Method 415.3 “Determination of Total Organic Carbon and Specific UV Absorbance at 254 nm in Source Water and Drinking Water,” Revision 1.2, September 2009, EPA/600/R-09/122. Available on the Internet at https://www.epa.gov/water-research/epa-drinking-water-research-methods.
(viii) Method 525.3 “Determination of Semivolatile Organic Chemicals in Drinking Water by Solid Phase Extraction and Capillary Column Gas Chromatography/Mass Spectrometry (GC/MS),” Version 1.0, February 2012, EPA/600/R-12/010. Available on the Internet https://www.epa.gov/water-research/epa-drinking-water-research-methods.
Gas(ii) Method 537.1, “Determination of Selected Per- and Polyfluorinated Alkyl Substances in Drinking Water by Solid Phase Extraction and
(GC/MS)Liquid Chromatography/Tandem Mass Spectrometry
1,” Version
January 2015, EPA/600/R-14/4422.0,
on the Internet2020. Available
x(
EPAiii)
541:Method
1-Butanol, 1,4-Dioxane, 2-Methoxyethanol and 2-Propen-1-ol533, “Determination of
Gas Chromatography/Mass Spectrometry,” November 2015, EPA 815-R-15-011. Available on the Internet at https://www.epa.gov/water-research/epa-drinking-water-research-methods. (xi) Method 544 “Determination of Microcystins and Nodularin in Drinking Water by Solid Phase Extraction andPer- and Polyfluoroalkyl Substances in Drinking Water by Isotope Dilution Anion Exchange Solid Phase Extraction and
(LC/MS/MS)Liquid Chromatography/Tandem Mass Spectrometry
Version 1.0, February 2015, EPA 600-R-14/474. Available on the Internet at https://www.epa.gov/water-research/epa-drinking-water-research-methods.,”
(xiii) EPA Method 546: “Determination of Total Microcystins and Nodularins in Drinking Water and Ambient Water by Adda Enzyme-Linked Immunosorbent Assay,” August 2016, EPA-815-B-16-011. Available on the Internet(xii) EPA Method 545: “Determination of Cylindrospermopsin and Anatoxin-a in Drinking Water by Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry (LC/ESI-MS/MS),” April 2015, EPA 815-R-15-009. Available on the Internet at https://www.epa.gov/dwanalyticalmethods.
November 2019, EPA 815-B-19-020. Available at https://www.epa.gov/dwanalyticalmethods.
xiv) Method 552.3 “Determination of Haloacetic Acids and Dalapon in Drinking Water by Liquid-Liquid Microextraction, Derivatization, and Gas Chromatography with Electron Capture Detection,” Revision 1.0, July 2003, EPA 815-B-03-002. Available on the Internet at https://www.epa.gov/dwanalyticalmethods.(
(xv) EPA Method 557: “Determination of Haloacetic Acids, Bromate, and Dalapon in Drinking Water by Ion Chromatography Electrospray Ionization Tandem Mass Spectrometry (IC-ESI-MS/MS),” Version 1.0, September 2009, EPA 815-B-09-012. Available on the Internet at https://www.epa.gov/dwanalyticalmethods.
((2) American Public Health Association - Standard Test Method for Elements in Water by Inductively Coupled Plasma-Mass Spectrometry,” approved August 1, 2010. Available for purchase on the Internet at http://www.astm.org/Standards/D5673.htm.
2) American Public Health Association, 800 I Street NW, Washington, DC 20001-3710; telephone: (202) 777-2742; email: comments@apha.org; www.apha.org.
(ii) The following methods are from(i) “Standard Methods for the Examination of Water & Wastewater,” 21st 23rd edition (20052017).
(A) SM 3125 3120 B, “Metals by Inductively Coupled Plasma/Mass Spectrometry.”
(C) SM 5310C “Total Organic Carbon (TOC): Persulfate-UV or Heated-Persulfate Oxidation(B) SM 5310B “Total Organic Carbon (TOC): High-Temperature Combustion Method.”
Plasma Emission Spectroscopy (2017): Inductively Coupled Plasma (ICP) Method.”
D) SM 5310D “Total Organic Carbon (TOC): Wet-Oxidation Method.”(
B) [Reserved]
(ii) “Standard Methods Online.,” approved 2000 (unless noted). Available for purchase on the Internet at http1999; https://www.standardmethods.org.
(A) SM 3125 3120 B, “Metals by Plasma Emission Spectroscopy: Inductively Coupled Plasma /Mass Spectrometry” Editorial revisions, 2011 (SM 3125-09).
(B) SM 5310B “Total Organic Carbon: High-Temperature Combustion Method,” (5310B-00).
(C) SM 5310C “Total Organic Carbon: Persulfate-UV or Heated-Persulfate Oxidation Method,” (5310C-00).
(D) SM 5310D “Total Organic Carbon: Wet-Oxidation Method,” (5310D-00).
(ICP) Method,” revised December 14, 2020.
(B) [Reserved]
(3) ASTM International, 100 Barr Harbor Drive, West Conshohocken, PA 19428-2959; telephone: (610) 832-9500; email: service@astm.org; www.astm.org.
(i) ASTM D5673D1976-10 20, “Standard Test Method for Elements in Water by Inductively-Coupled Plasma -Mass SpectrometryAtomic Emission Spectroscopy,” approved August May 1, 2010. Available for purchase on the Internet at http://www.astm.org/Standards/D5673.htm.
(ii) ASTM D6581-12 “Standard Test Methods for Bromate, Bromide, Chlorate, and Chlorite in Drinking Water by Suppressed Ion Chromatography,” approved March 1, 2012. Available for purchase on the Internet at http://www.astm.org/Standards/D6581.htm.
2020.
(ii) [Reserved]
[72 FR 393, Jan. 4, 2007; 72 FR 3916, Jan. 26, 2007, as amended at 77 FR 26098, May 2, 2012; 81 FR 92688, Dec. 20, 2016; 86 FR 73155, Dec. 27, 2021; 87 FR 3679, Jan. 25, 2022]